About Dual AAV
Dual AAV vectors split your gene into two vectors that under in-vivo homologous recombination, reforms to produce a full gene product. These are used when payloads >4.7kb are required.
Dual AAV vector controls contain two AAV vectors, with each vector carrying half of a GFP reporter gene. When recombined, a functional GFP is formed, allowing quick visual read-out.
Your team can use dual AAV vector controls to de-risk projects, for proof-of-principle studies, and to optimize parameters before moving into larger, more complex experiments. These controls are available in a wide range of promoters for tissue targeting.
Features
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
AAV-h-APOM-shRNA
Cat No: shAAV-201216
Availability: 6-8 weeks
AAV-h-APOO-shRNA
Cat No: shAAV-201217
Availability: 4-5 weeks
AAV-h-APOOL-shRNA
Cat No: shAAV-201220
Availability: 6-8 weeks
AAV-h-APP-shRNA
Cat No: shAAV-201221
Availability: Immediate
AAV-h-APPBP2-shRNA
Cat No: shAAV-201222
Availability: 4-5 weeks
AAV-h-APPL1-shRNA
Cat No: shAAV-201223
Availability: 4-5 weeks
AAV-h-APPL2-shRNA
Cat No: shAAV-201224
Availability: 6-8 weeks
AAV-h-APRT-shRNA
Cat No: shAAV-201225
Availability: 4-5 weeks
AAV-h-APTX-shRNA
Cat No: shAAV-201227
Availability: 4-5 weeks
AAV-h-AQP1-shRNA
Cat No: shAAV-201228
Availability: 6-8 weeks
AAV-h-AQP10-shRNA
Cat No: shAAV-201229
Availability: 6-8 weeks
AAV-h-AQP11-shRNA
Cat No: shAAV-201232
Availability: 4-5 weeks
